Randomized assessment shows economic growth and ethical advantages of non-animal methodologies, highlighting significant potential for the UK life sciences sector.
Key Points
To assess the economic impact and effectiveness of non-animal new approach methodologies (NAMs) in the UK commercial sector.
Analysis of Companies House and Annual Business Survey data for 75 firms from 2021-2024.
Projection of sector turnover and employment growth to 2030.
Evaluation of public investment returns in NAMs compared to animal-based research.
Sector turnover grew from £947 million to £1.24 billion with 9.4% annual growth rate.
Gross Value Added (GVA) increased from £212 million to £277 million, with employment expanding by 12.8% per annum.
Projected turnover of £2.12 billion and employment exceeding 12,000 by 2030 under current growth trajectories.